Fulgent Genetics, Inc. (FLGT)
24.80
+0.58
(+2.42%)
USD |
NASDAQ |
Nov 18, 12:52
Fulgent Genetics Cash and Short Term Investments (Quarterly) : 292.74M for Sept. 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 292.74M |
| June 30, 2026 | 257.03M |
| March 31, 2026 | 276.30M |
| December 31, 2025 | 336.08M |
| September 30, 2025 | 375.80M |
| June 30, 2025 | 292.93M |
| March 31, 2025 | 320.32M |
| December 31, 2024 | 258.11M |
| September 30, 2024 | 213.07M |
| June 30, 2024 | 311.71M |
| March 31, 2024 | 305.70M |
| December 31, 2023 | 424.15M |
| September 30, 2023 | 467.80M |
| June 30, 2023 | 458.43M |
| March 31, 2023 | 504.48M |
| December 31, 2022 | 526.24M |
| September 30, 2022 | 571.06M |
| June 30, 2022 | 515.40M |
| March 31, 2022 | 585.11M |
| December 31, 2021 | 450.50M |
| September 30, 2021 | 469.98M |
| June 30, 2021 | 383.79M |
| Date | Value |
|---|---|
| March 31, 2021 | 409.78M |
| December 31, 2020 | 299.37M |
| September 30, 2020 | 74.94M |
| June 30, 2020 | 20.96M |
| March 31, 2020 | 27.33M |
| December 31, 2019 | 28.27M |
| September 30, 2019 | 32.12M |
| June 30, 2019 | 26.98M |
| March 31, 2019 | 29.43M |
| December 31, 2018 | 31.03M |
| September 30, 2018 | 32.60M |
| June 30, 2018 | 30.60M |
| March 31, 2018 | 28.48M |
| December 31, 2017 | 26.48M |
| September 30, 2017 | 26.05M |
| June 30, 2017 | 28.87M |
| March 31, 2017 | 27.37M |
| December 31, 2016 | 20.87M |
| September 30, 2016 | 8.205M |
| June 30, 2016 | 16.06M |
| March 31, 2016 | |
| December 31, 2015 | 0.489M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Quest Diagnostics, Inc. | 797.00M |
| Labcorp Holdings, Inc. | 261.80M |
| OPKO Health, Inc. | 390.22M |
| Psychemedics Corp. | -- |
| NeoGenomics, Inc. | 139.28M |